These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 25886924)

  • 1. Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
    OʼDonnell MR; Pillay M; Pillay M; Werner L; Master I; Wolf A; Mathema B; Coovadia YM; Mlisana K; Horsburgh CR; Padayatchi N
    J Acquir Immune Defic Syndr; 2015 Aug; 69(5):536-43. PubMed ID: 25886924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosis.
    Pietersen E; Peter J; Streicher E; Sirgel F; Rockwood N; Mastrapa B; Te Riele J; Davids M; van Helden P; Warren R; Dheda K
    PLoS One; 2015; 10(4):e0123655. PubMed ID: 25909847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
    Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
    PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Antiretroviral Therapy on Treatment Outcomes in a Prospective Study of Extensively Drug-Resistant Tuberculosis (XDR-TB) HIV Coinfection Treatment in KwaZulu-Natal, South Africa.
    Yuengling KA; Padayatchi N; Wolf A; Mathema B; Brown T; Horsburgh CR; OʼDonnell MR
    J Acquir Immune Defic Syndr; 2018 Dec; 79(4):474-480. PubMed ID: 30212394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa.
    Müller B; Chihota VN; Pillay M; Klopper M; Streicher EM; Coetzee G; Trollip A; Hayes C; Bosman ME; Gey van Pittius NC; Victor TC; Gagneux S; van Helden PD; Warren RM
    PLoS One; 2013; 8(8):e70919. PubMed ID: 24058399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.
    Pillay M; Sturm AW
    Clin Infect Dis; 2007 Dec; 45(11):1409-14. PubMed ID: 17990220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand.
    Sowajassatakul A; Prammananan T; Chaiprasert A; Phunpruch S
    BMC Microbiol; 2014 Jun; 14():165. PubMed ID: 24953243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization and second-line antituberculosis drug resistance patterns of multidrug-resistant Mycobacterium tuberculosis isolates from the northern region of South Africa.
    Said HM; Kock MM; Ismail NA; Mphahlele M; Baba K; Omar SV; Osman AG; Hoosen AA; Ehlers MM
    J Clin Microbiol; 2012 Sep; 50(9):2857-62. PubMed ID: 22649019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clofazimine in the treatment of extensively drug-resistant tuberculosis with HIV coinfection in South Africa: a retrospective cohort study.
    Padayatchi N; Gopal M; Naidoo R; Werner L; Naidoo K; Master I; O'Donnell MR
    J Antimicrob Chemother; 2014 Nov; 69(11):3103-7. PubMed ID: 24986495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal diversity of drug-resistant Mycobacterium tuberculosis strains, South Africa.
    Gandhi NR; Brust JC; Moodley P; Weissman D; Heo M; Ning Y; Moll AP; Friedland GH; Sturm AW; Shah NS
    Emerg Infect Dis; 2014 Mar; 20(3):426-33. PubMed ID: 24565645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in Rural China.
    Hu Y; Hoffner S; Wu L; Zhao Q; Jiang W; Xu B
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3857-63. PubMed ID: 23733477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
    Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
    Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa.
    Andrews JR; Gandhi NR; Moodley P; Shah NS; Bohlken L; Moll AP; Pillay M; Friedland G; Sturm AW;
    J Infect Dis; 2008 Dec; 198(11):1582-9. PubMed ID: 18847372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011.
    Nguyen HB; Nguyen NV; Tran HT; Nguyen HV; Bui QT
    Western Pac Surveill Response J; 2016; 7(2):35-40. PubMed ID: 27508089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission of Extensively Drug-Resistant Tuberculosis in South Africa.
    Shah NS; Auld SC; Brust JC; Mathema B; Ismail N; Moodley P; Mlisana K; Allana S; Campbell A; Mthiyane T; Morris N; Mpangase P; van der Meulen H; Omar SV; Brown TS; Narechania A; Shaskina E; Kapwata T; Kreiswirth B; Gandhi NR
    N Engl J Med; 2017 Jan; 376(3):243-253. PubMed ID: 28099825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensively drug-resistant TB in Eastern Cape, South Africa: high mortality in HIV-negative and HIV-positive patients.
    Kvasnovsky CL; Cegielski JP; Erasmus R; Siwisa NO; Thomas K; der Walt ML
    J Acquir Immune Defic Syndr; 2011 Jun; 57(2):146-52. PubMed ID: 21297482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa.
    Mlambo CK; Warren RM; Poswa X; Victor TC; Duse AG; Marais E
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):99-104. PubMed ID: 18173885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spread of extensively drug-resistant tuberculosis in KwaZulu-Natal province, South Africa.
    Moodley P; Shah NS; Tayob N; Connolly C; Zetola N; Gandhi N; Friedland G; Sturm AW
    PLoS One; 2011; 6(5):e17513. PubMed ID: 21655324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased in vitro fitness of multi- and extensively drug-resistant F15/LAM4/KZN strains of Mycobacterium tuberculosis.
    Naidoo CC; Pillay M
    Clin Microbiol Infect; 2014 Jun; 20(6):O361-9. PubMed ID: 24118525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial transmission of the F15/LAM4/KZN genotype of Mycobacterium tuberculosis in patients on tuberculosis treatment.
    Pillay M; Sturm AW
    Int J Tuberc Lung Dis; 2010 Feb; 14(2):223-30. PubMed ID: 20074415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.